ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.

CTEC Convatec Group Plc

282.60
-1.00 (-0.35%)
19 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Convatec Group Plc LSE:CTEC London Ordinary Share GB00BD3VFW73 ORD 10P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -1.00 -0.35% 282.60 282.60 283.00 283.20 279.80 281.80 4,198,441 16:29:55
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Med, Dental, Hosp Eq-whsl 2.14B 130.3M 0.0636 44.43 5.79B

ConvaTec Group PLC Director/PDMR Shareholding (5107X)

28/08/2020 3:54pm

UK Regulatory


Convatec (LSE:CTEC)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Convatec Charts.

TIDMCTEC

RNS Number : 5107X

ConvaTec Group PLC

28 August 2020

28 August 2020

ConvaTec Group Plc

("ConvaTec" or "the Company")

Director/PDMR Shareholding

The Company has been notified of the following transaction by a Person Discharging Managerial Responsibility ("PDMR") in ordinary shares of 10 pence each in the share capital of the Company ("Shares").

On 25 August 2020, Heather Mason, Non-Executive Director and PDMR, purchased 10,000 Shares at GBP1.978688 per share. Ms Mason's resulting shareholding is 10,000 Shares.

The attached notification, made in accordance with the requirements of the EU Market Abuse Regulation, gives further detail.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 
  1      Details of the person discharging managerial responsibilities/person 
          closely associated 
  a)    Name                                              Heather Mason 
  2     Reason for the notification 
  a)    Position/Status                                   Non-Executive Director 
  b)    Initial notification/Amendment                    Initial notification 
  3     Details of the issuer, emission allowance market participant, 
         auction platform, auctioneer or auction monitor 
  a)    Name                                              ConvaTec Group Plc 
  b)    LEI                                               213800LS272L4FIDOH92 
  4     Details of the transaction(s): section to be repeated for 
         (i) each type of instrument; (ii) each type of transaction; 
         (iii) each date; and (iv) each place where transactions have 
         been conducted 
  a)    Description of the financial                      Ordinary shares of 10p each in ConvaTec Group Plc ("Shares") 
         instrument, type of instrument                    GB00BD3VFW73 
         Identification code 
  b)    Nature of the transaction                          Purchase of Shares on 25 August 2020 
  c)    Price(s) and volume(s)                            Price(s)                                         Volume(s) 
                                                           GBP1.978688                                      10,000 
  d)    Aggregated information 
         - Aggregated volume                                10,000 
         - Price                                            GBP19.786.88 
  e)    Date of the transaction                           25 August 2020 
  f)    Place of the transaction                          London Stock Exchange, Main Market (XLON) 
 
 

Enquiries

Analysts and Investors

Mark Reynolds, Director Investor Relations +44 (0)7551 036 625

investorrelations@convatec.com

Media

 
Buchanan                                                       +44 (0)207 466 5000 
Charles Ryland/Chris Lane/Vicky Hayns 
 

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

About ConvaTec

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion devices. ConvaTec's products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com where a copy of this announcement can also be found.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFLFESTLITFII

(END) Dow Jones Newswires

August 28, 2020 10:54 ET (14:54 GMT)

1 Year Convatec Chart

1 Year Convatec Chart

1 Month Convatec Chart

1 Month Convatec Chart

Your Recent History

Delayed Upgrade Clock